Table of Content




1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Key Growth Enablers
2.5. Key Challenges

3. Key Analytics
3.1. Impact Of Covid-19 On Stem Cell Market
3.2. Key Market Trends
3.3. Pestle Analysis
3.4. Porter’S Five Forces Analysis
3.4.1. Buyers Power
3.4.2. Suppliers Power
3.4.3. Substitution
3.4.4. New Entrants
3.4.5. Industry Rivalry
3.5. Opportunity Matrix
3.6. Vendor Landscape
3.7. Value Chain Analysis
3.8. Key Buying Criteria
3.8.1. Price
3.8.2. Efficacy
3.8.3. Application And Effectiveness
3.8.4. Accuracy
3.9. Regulatory Framework

4. Market By Therapeutic Application
4.1. Orthopedic Treatments
4.2. Injuries & Wounds
4.3. Oncology Disorders
4.4. Cardiovascular Disorders
4.5. Neurological Disorders
4.6. Diabetes
4.7. Other Therapeutic Applications

5. Market By Product
5.1. Adult Stem Cell
5.1.1. Hematopoietic Stem Cell
5.1.2. Neural Stem Cell
5.1.3. Umbilical Cord Stem Cell
5.1.4. Mesenchymal Stem Cell
5.1.5. Dental Stem Cell
5.2. Human Embryonic Stem Cell
5.3. Pluripotent
5.4. Mouse/Rat Neural

6. Market By Technology
6.1. Cell Acquisition
6.1.1. Bone Marrow Harvest
6.1.2. Umbilical Cord
6.1.3. Apheresis
6.2. Cell Production
6.2.1. Therapeutic Cloning
6.2.2. In Vitro Fertilization (Ivf)
6.2.3. Cell Culture
6.2.4. Isolation
6.3. Cryopreservation
6.4. Expansion & Sub-Culture

7. Market By Application
7.1. Regenerative Medicine
7.2. Drug Discovery And Development

8. Market By Treatment Type
8.1. Allogeneic Stem Cell Therapy
8.2. Autologic Stem Cell Therapy
8.3. Syngeneic Stem Cell Therapy

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Acquisitions
9.1.2. Partnerships
9.2. Company Profiles
9.2.1. Corning Inc
9.2.2. Ge Healthcare
9.2.3. Merck Kgaa (Sigma Aldrich)
9.2.4. Qiagen
9.2.5. Smith+Nephew Plc
9.2.6. Takara Holdings Inc
9.2.7. Thermo Fisher Scientific Inc



List of Figures


List Of Figures
Figure 1: Key Market Trends
Figure 2: Stem Cell Screening Strategies And Their Potential Application
Figure 3: Pestle Analysis
Figure 4: Porter’S Five Forces Analysis
Figure 5: Opportunity Matrix
Figure 6: Vendor Landscape
Figure 7: Value Chain Analysis
Figure 8: Key Buying Criteria
Figure 9: Australia & New Zealand Stem Cell Market, Growth Potential, By Therapeutic Application, In 2021
Figure 10: Australia & New Zealand Stem Cell Market, By Orthopedic Treatments, 2022-2028 (In $ Million)
Figure 11: Australia & New Zealand Stem Cell Market, By Injuries & Wounds, 2022-2028 (In $ Million)
Figure 12: Australia & New Zealand Stem Cell Market, By Oncology Disorders, 2022-2028 (In $ Million)
Figure 13: Australia & New Zealand Stem Cell Market, By Cardiovascular Disorders, 2022-2028 (In $ Million)
Figure 14: Australia & New Zealand Stem Cell Market, By Neurological Disorders, 2022-2028 (In $ Million)
Figure 15: Australia & New Zealand Stem Cell Market, By Diabetes, 2022-2028 (In $ Million)
Figure 16: Australia & New Zealand Stem Cell Market, By Other Therapeutic Applications, 2022-2028 (In $ Million)
Figure 17: Australia & New Zealand Stem Cell Market, Growth Potential, By Product, In 2021
Figure 18: Australia & New Zealand Stem Cell Market, By Adult Stem Cell Market, 2022-2028 (In $ Million)
Figure 19: Australia & New Zealand Stem Cell Market, Growth Potential, By Adult Stem Cell, In 2021
Figure 20: Australia & New Zealand Stem Cell Market, By Hematopoietic Stem Cell Market, 2022-2028 (In $ Million)
Figure 21: Australia & New Zealand Stem Cell Market, By Neural Stem Cell Market, 2022-2028 (In $ Million)
Figure 22: Australia & New Zealand Stem Cell Market, By Umbilical Cord Stem Cell Market, 2022-2028 (In $ Million)
Figure 23: Australia & New Zealand Stem Cell Market, By Mesenchymal Stem Cell Market, 2022-2028 (In $ Million)
Figure 24: Australia & New Zealand Stem Cell Market, By Dental Stem Cell Market, 2022-2028 (In $ Million)
Figure 25: Australia & New Zealand Stem Cell Market, By Human Embryonic Stem Cell, 2022-2028 (In $ Million)
Figure 26: Australia & New Zealand Stem Cell Market, By Pluripotent, 2022-2028 (In $ Million)
Figure 27: Australia & New Zealand Stem Cell Market, By Mouse/Rat Neural, 2022-2028 (In $ Million)
Figure 28: Australia & New Zealand Stem Cell Market, Growth Potential, By Technology, In 2021
Figure 29: Australia & New Zealand Stem Cell Market, By Cell Acquisition, 2022-2028 (In $ Million)
Figure 30: Australia & New Zealand Stem Cell Market, Growth Potential, By Cell Acquisition, In 2021
Figure 31: Australia & New Zealand Stem Cell Market, By Bone Marrow Harvest, 2022-2028 (In $ Million)
Figure 32: Australia & New Zealand Stem Cell Market, By Umbilical Cord, 2022-2028 (In $ Million)
Figure 33: Australia & New Zealand Stem Cell Market, By Apheresis, 2022-2028 (In $ Million)
Figure 34: Australia & New Zealand Stem Cell Market, By Cell Production, 2022-2028 (In $ Million)
Figure 35: Australia & New Zealand Stem Cell Market, Growth Potential, By Cell Production, In 2021
Figure 36: Australia & New Zealand Stem Cell Market, By Therapeutic Cloning, 2022-2028 (In $ Million)
Figure 37: Australia & New Zealand Stem Cell Market, By In Vitro Fertilization (Ivf), 2022-2028 (In $ Million)
Figure 38: Australia & New Zealand Stem Cell Market, By Cell Culture, 2022-2028 (In $ Million)
Figure 39: Australia & New Zealand Stem Cell Market, By Isolation, 2022-2028 (In $ Million)
Figure 40: Australia & New Zealand Stem Cell Market, By Cryopreservation, 2022-2028 (In $ Million)
Figure 41: Australia & New Zealand Stem Cell Market, By Expansion & Sub-Culture, 2022-2028 (In $ Million)
Figure 42: Australia & New Zealand Stem Cell Market, Growth Potential, By Application, In 2021
Figure 43: Australia & New Zealand Stem Cell Market, By Regenerative Medicine, 2022-2028 (In $ Million)
Figure 44: Australia & New Zealand Stem Cell Market, By Drug Discovery And Development, 2022-2028 (In $ Million)
Figure 45: Australia & New Zealand Stem Cell Market, Growth Potential, By Treatment Type, In 2021
Figure 46: Australia & New Zealand Stem Cell Market, By Allogeneic Stem Cell Therapy, 2022-2028 (In $ Million)
Figure 47: Australia & New Zealand Stem Cell Market, By Autologic Stem Cell Therapy, 2022-2028 (In $ Million)
Figure 48: Australia & New Zealand Stem Cell Market, By Syngeneic Stem Cell Therapy, 2022-2028 (In $ Million)

List of Tables


LIST OF TABLES
TABLE 1: AUSTRALIA & NEW ZEALAND - COUNTRY SNAPSHOT
TABLE 2: EXAMPLES OF APPROVED CELL THERAPY PRODUCTS
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 6: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 8: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ADULT STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ADULT STEM CELL, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 10: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 12: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL ACQUISITION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL ACQUISITION, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 14: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL PRODUCTION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL PRODUCTION, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 16: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 18: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 19: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 20: LIST OF ACQUISITIONS
TABLE 21: LIST OF PARTNERSHIPS